ResearcherHarvard UniversityActive in the last 2 years

Sangwoo Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2701-3114; OpenAlex author ID A5100776709. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-25-2907 ↗
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. Co-author DOI 10.1038/s41467-025-66102-2 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Giulia Escobar · 2 shared papers, 2025–2026 · strength 0.47
- Paper Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Canc… DOI 10.1158/1078-0432.ccr-25-2907 ↗
- Paper Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. DOI 10.1038/s41467-025-66102-2 ↗
Marcela Valderrama Maus · 2 shared papers, 2025–2026 · strength 0.47
- Paper Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Canc… DOI 10.1158/1078-0432.ccr-25-2907 ↗
- Paper Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. DOI 10.1038/s41467-025-66102-2 ↗
Diego Salas‐Benito · 2 shared papers, 2025–2026 · strength 0.47
- Paper Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Canc… DOI 10.1158/1078-0432.ccr-25-2907 ↗
- Paper Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. DOI 10.1038/s41467-025-66102-2 ↗
Alexander Armstrong · 1 shared paper, 2026 · strength 0.25
- Paper Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Canc… DOI 10.1158/1078-0432.ccr-25-2907 ↗
Eli P. Darnell · 1 shared paper, 2025 · strength 0.22
- Paper Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. DOI 10.1038/s41467-025-66102-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.